177 related articles for article (PubMed ID: 29864910)
1. Berberine suppresses growth and metastasis of endometrial cancer cells via miR-101/COX-2.
Wang Y; Zhang S
Biomed Pharmacother; 2018 Jul; 103():1287-1293. PubMed ID: 29864910
[TBL] [Abstract][Full Text] [Related]
2. Berberine inhibits the development of endometrial cancer through circ_ZNF608/miR-377-3p/COX2 axis.
Liang H; Liu Y; Fu L; Li L; Gong N
Autoimmunity; 2022 Nov; 55(7):485-495. PubMed ID: 35876160
[TBL] [Abstract][Full Text] [Related]
3. Berberine Inhibits Invasion and Metastasis of Colorectal Cancer Cells via COX-2/PGE2 Mediated JAK2/STAT3 Signaling Pathway.
Liu X; Ji Q; Ye N; Sui H; Zhou L; Zhu H; Fan Z; Cai J; Li Q
PLoS One; 2015; 10(5):e0123478. PubMed ID: 25954974
[TBL] [Abstract][Full Text] [Related]
4. Berberine Targets AP-2/hTERT, NF-κB/COX-2, HIF-1α/VEGF and Cytochrome-c/Caspase Signaling to Suppress Human Cancer Cell Growth.
Fu L; Chen W; Guo W; Wang J; Tian Y; Shi D; Zhang X; Qiu H; Xiao X; Kang T; Huang W; Wang S; Deng W
PLoS One; 2013; 8(7):e69240. PubMed ID: 23869238
[TBL] [Abstract][Full Text] [Related]
5. Berberine inhibits the proliferation, invasion and migration of endometrial stromal cells by downregulating miR‑429.
Gu Y; Zhou Z
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846796
[TBL] [Abstract][Full Text] [Related]
6. Berberine, a natural compound, suppresses Hedgehog signaling pathway activity and cancer growth.
Wang J; Peng Y; Liu Y; Yang J; Ding N; Tan W
BMC Cancer; 2015 Aug; 15():595. PubMed ID: 26296751
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-101 inhibits angiogenesis via COX-2 in endometrial carcinoma.
Liu Y; Li H; Zhao C; Jia H
Mol Cell Biochem; 2018 Nov; 448(1-2):61-69. PubMed ID: 29404887
[TBL] [Abstract][Full Text] [Related]
8. Berberine inhibits gastric cancer development and progression by regulating the JAK2/STAT3 pathway and downregulating IL-6.
Xu M; Ren L; Fan J; Huang L; Zhou L; Li X; Ye X
Life Sci; 2022 Feb; 290():120266. PubMed ID: 34968467
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-505 functions as a tumor suppressor in endometrial cancer by targeting TGF-α.
Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y
Mol Cancer; 2016 Feb; 15():11. PubMed ID: 26832151
[TBL] [Abstract][Full Text] [Related]
10. Berberine Inhibits Uterine Leiomyoma Cell Proliferation via Downregulation of Cyclooxygenase 2 and Pituitary Tumor-Transforming Gene 1.
Chuang TY; Min J; Wu HL; McCrary C; Layman LC; Diamond MP; Azziz R; Al-Hendy A; Chen YH
Reprod Sci; 2017 Jul; 24(7):1005-1013. PubMed ID: 27799459
[TBL] [Abstract][Full Text] [Related]
11. Berberine suppresses bladder cancer cell proliferation by inhibiting JAK1-STAT3 signaling via upregulation of miR-17-5p.
Xia Y; Chen S; Cui J; Wang Y; Liu X; Shen Y; Gong L; Jiang X; Wang W; Zhu Y; Sun S; Li J; Zou Y; Shi B
Biochem Pharmacol; 2021 Jun; 188():114575. PubMed ID: 33887260
[TBL] [Abstract][Full Text] [Related]
12. LINC00461 Promoted Endometrial Carcinoma Growth and Migration by Targeting MicroRNA-219-5p/Cyclooxygenase-2 Signaling Axis.
Wang Y; Yin L
Cell Transplant; 2021; 30():963689721989616. PubMed ID: 33573388
[TBL] [Abstract][Full Text] [Related]
13. The enhancement of combination of berberine and metformin in inhibition of DNMT1 gene expression through interplay of SP1 and PDPK1.
Zheng F; Wu J; Tang Q; Xiao Q; Wu W; Hann SS
J Cell Mol Med; 2018 Jan; 22(1):600-612. PubMed ID: 28840963
[TBL] [Abstract][Full Text] [Related]
14. Exploring the active mechanism of berberine against HCC by systematic pharmacology and experimental validation.
Song L; Luo Y; Wang X; Almutairi MM; Pan H; Li W; Liu Y; Wang Q; Hong M
Mol Med Rep; 2019 Nov; 20(5):4654-4664. PubMed ID: 31545468
[TBL] [Abstract][Full Text] [Related]
15. The effects of microRNA-183 promots cell proliferation and invasion by targeting MMP-9 in endometrial cancer.
Ruan H; Liang X; Zhao W; Ma L; Zhao Y
Biomed Pharmacother; 2017 May; 89():812-818. PubMed ID: 28273643
[TBL] [Abstract][Full Text] [Related]
16. Berberine induces apoptosis by suppressing the arachidonic acid metabolic pathway in hepatocellular carcinoma.
Li J; Li O; Kan M; Zhang M; Shao D; Pan Y; Zheng H; Zhang X; Chen L; Liu S
Mol Med Rep; 2015 Sep; 12(3):4572-4577. PubMed ID: 26081696
[TBL] [Abstract][Full Text] [Related]
17. Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.
Dong P; Ihira K; Xiong Y; Watari H; Hanley SJ; Yamada T; Hosaka M; Kudo M; Yue J; Sakuragi N
Oncotarget; 2016 Apr; 7(15):20260-70. PubMed ID: 26934121
[TBL] [Abstract][Full Text] [Related]
18. Systematic analysis of berberine-induced signaling pathway between miRNA clusters and mRNAs and identification of mir-99a ∼ 125b cluster function by seed-targeting inhibitors in multiple myeloma cells.
Feng M; Luo X; Gu C; Li Y; Zhu X; Fei J
RNA Biol; 2015; 12(1):82-91. PubMed ID: 25826415
[TBL] [Abstract][Full Text] [Related]
19. miR-652 Promotes Tumor Proliferation and Metastasis by Targeting
Sun X; Dongol S; Qiu C; Xu Y; Sun C; Zhang Z; Yang X; Zhang Q; Kong B
Mol Cancer Res; 2018 Dec; 16(12):1927-1939. PubMed ID: 30093563
[TBL] [Abstract][Full Text] [Related]
20. miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer.
He Z; Xu H; Meng Y; Kuang Y
Biomed Pharmacother; 2017 Apr; 88():902-910. PubMed ID: 28178620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
